Aarey Drugs & Pharmaceuticals

quarterly
yearly
ParticularsSep '22Dec '22Mar '23Jun '23Sep '23
Revenue75.3262.95163.7251.6658.67
Expenses72.9962.20161.5850.9357.66
EBITDA3.342.013.372.032.69
EBIT2.911.462.351.141.42
Profit Before Tax2.330.742.140.721.00
Net Profit2.120.490.360.720.78
Financial Ratios
Operating Profit Margin4.37%3.22%2.06%4.00%4.63%
Net Profit Margin2.78%0.78%0.22%1.41%1.35%
Earning Per Share (Diluted)0.830.190.140.290.31
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.5.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ